Context Therapeutics, Inc. (CNTX)
2.36
+0.19
(+8.76%)
USD |
NASDAQ |
Feb 10, 16:00
2.31
-0.05
(-2.12%)
After-Hours: 07:10
Context Therapeutics EPS Diluted (Quarterly) : -0.1018 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.693M |
| Total Expenses (Quarterly) | 9.693M |
| Enterprise Value | 140.04M |
| Earnings Yield | -11.86% |
| Normalized Earnings Yield | -11.86 |